Differences in cardiovascular mortality rates among hemodialysis patients in the United States and Japan: The importance of background cardiovascular mortality

Hemodialysis International

Volumn 8, Issue 4, 2004, Pages 394-399

  Kuhlmann, Martin K ^a   Yoshino, Maki ^a   Levin, Nathan W ^a  

^a RENAL RESEARCH INSTITUTE   (United States)

Author keywords

Cardiovascular; Chronic hemodialysis; Japan; Mortality; United States

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; BETA1 INTEGRIN; BLOOD CLOTTING FACTOR 5 LEIDEN; CD14 ANTIGEN; CD31 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; LYMPHOTOXIN; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ASIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE PREDISPOSITION; EASTERN EUROPE; ETHNIC DIFFERENCE; EUROPE; FACTUAL DATABASE; FREQUENCY ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOTHESIS; JAPAN; LINEAR SYSTEM; MORTALITY; REVIEW; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 21644451963     PISSN: 14927535     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1492-7535.2004.80416.x     Document Type: Review

References (21)

1. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis. 1990; 15(5): 451-457.
2. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held FJ, Young EW. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States. The Dialysis Outcomes Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003; 14(12): 3270-3277.
3. Kjellstrand CM, Blagg CR. Differences in dialysis practice are the main reasons for the high mortality rate in the United States compared to Japan. Hemodial Int. 2003; 7(1): 67.
4. Young EW, Goodkin DA, Mapes DL, Port FK, Keen ML, Chen K, Maroni BL, Wolfe RA, Held PJ. The Dialysis Outcomes and Practice Patterns Study: An international hemodialysis study. Kidney Int. 2000; 57(Suppl 74): S74-S81.
5. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held PJ, Port FK. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004; 44(1): 94-111.
6. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis. 1998; 31(4): 607-617.
7. Young E, Satayathum S, Pisoni R, Locatelli F, Canaud B, Kurokawa K, Akiba T, Saito A, Mapes D, Port F. Prevalence of values on mineral metabolism being outside the targets from the proposed new draft NKF-K/DOQI and European Best Practice Guidelines in countries of the Dialysis Outcomes and Practice Patterns Study (DOPPS) [abstract]. Nephrol Dial Transplant. 2003; 18(Suppl 4): 677 (W414).
8. Goodkin DA, Dickinson DM, Rasmussen CS, Kurokawa K, Akiba A, Held FJ. Components of hemodialysis dose: Results from 7 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) [abstract]. J Am Soc Nephrol. 2000; 11: 320A.
9. Port FK, Rasmussen CS, Leavey SF, Wolfe RA, Kurokawa K, Akizawa T, Saito A, Piera L, Held PJ, Young EW. Association of blood flow rate (BFR) and treatment time (TT) with mortality risk (RR) in hemodialysis (HD) patients across three continents [abstract]. J Am Soc Nephrol. 2001; 12: 343A.
10. Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2002; 61(6): 2266-2271.
11. Pisoni RL, Young EW, Mapes DL, Keen ML, Port FK. Vascular access use and outcomes in the U.S., Europe, and Japan: Results from the Dialysis Outcomes and Practice Patterns Study. Nephrol News Issues. 2003; 17(6): 38-43.
12. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994; 330(15): 1041-1046.
13. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A and methyleneretrahydrofolate reductase C677T mutation and events of the arterial circulatory system: A meta-analysis of published studies. Am Heart J. 2003; 146(6): 948-957.
14. Kolovou G, Daslakova D, Mikhailidis DP. Apolipoprotein E polymorphism and atherosclerosis. Angiology. 2003; 54(1): 59-71.
15. Shicji K, Nishioka J, Naraba H, Kokubo Y, Mannami T, Inamoto N, Kamide K, Takiuchi S, Yoshii M, Miwa Y, Kawano Y, Miyata T, Miyazaki S, Goto Y, Nonogi H, Tago N, Iwai N. A promoter variant of the ATP-binding cassette transporter Al1gene alters the HDL cholesterol levels in the general Japanese population. J Hum Genet. 2004; 49(3): 141-147.
16. Park KW, You KH, Oh S, Chae IH, Kim HS, Oh BH, Lee MM, Park YB. Association of endothelial constitutive nitric oxide synthase gene polymorphism with acute coronary syndrome in Koreans. Heart. 2004; 90(3): 282-285.
17. Andreotti F, Porto I, Crea F, Maseri A. Inflammatory gene polymorphism and ischemic heart disease: Review of population association studies. Heart. 2002; 87(2): 107-112.
18. Girndt M, Kaul H, Sester U, Ulrich C, Sester M, Georg T, Kohler H. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int. 2002; 62(3): 949-955.
19. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottif U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hadonarson H, Gulcher JR, Stefansson K. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet. 2004; 36(3): 233-239.
20. Humphries SE, Talmund PJ, Hawe E, Bolla M, Day IN, Miller GJ. Apolipoprotein E4 and coronary artery disease in middle aged men who smoke: A prospective study. Lancet. 2002; 358: 115-119.
21. Martinelli N, Girelli D, Olivieri O, Stranieri C, Trabetti E, Pizzolo F, Friso S, Tenuti I, Cheng S, Grow MA, Pignatti PF, Corrocher R. Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction. Eur J Clin Invest. 2004; 34(1): 14-20.